Cancer victims argue the proposed $7.25 billion Roundup "sweetheart deal" benefits Bayer and lawyers more than those harmed by the herbicide.

By Renee Hickman and Tom Polansek CHICAGO, June 2 (Reuters) - Bayer has no plans to spin off Monsanto, a representative said on Tuesday, even as the company faces an avalanche of lawsuits over its ...

Case centers on glyphosate, pesticide used in Roundup and other products that has been linked to cancer in some studies ...

Bayer has no plans to spin off Monsanto, a company representative told Reuters, even as the company faces a flurry of ...

NASHVILLE, Tenn. (WKRN) — Glyphosate, the key ingredient in Roundup and one of the most widely used weedkillers in the country, is again at the center of a national fight that now stretches into ...

The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the weedkiller Roundup failed to warn people it could cause cancer. The case came before the ...

Bayer-owned agriculture firm Monsanto was ordered to pay $289 million to a groundskeeper who alleged that the ingredients of ...

Brazilian prosecutors are suing health agency Anvisa and the federal government to ban the use of top-selling weed killer glyphosate, dealing a potential blow to chemical companies in Latin America’s ...

The manufacturer of the top-selling weed-killer Roundup has changed the product's formula after many lawsuits.